Harpoon Therapeutics Inc
NASDAQ:HARP
Harpoon Therapeutics Inc
Revenue
Harpoon Therapeutics Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Harpoon Therapeutics Inc
NASDAQ:HARP
|
Revenue
$31.9m
|
CAGR 3-Years
77%
|
CAGR 5-Years
114%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
Harpoon Therapeutics Inc
Revenue Breakdown
Breakdown by Geography
Harpoon Therapeutics Inc
Breakdown by Segments
Harpoon Therapeutics Inc
Total Revenue:
31.9m
USD
|
Collaboration And License:
31.9m
USD
|
See Also
What is Harpoon Therapeutics Inc's Revenue?
Revenue
31.9m
USD
Based on the financial report for Dec 31, 2022, Harpoon Therapeutics Inc's Revenue amounts to 31.9m USD.
What is Harpoon Therapeutics Inc's Revenue growth rate?
Revenue CAGR 5Y
114%
Over the last year, the Revenue growth was 35%. The average annual Revenue growth rates for Harpoon Therapeutics Inc have been 77% over the past three years , 114% over the past five years .